518 related articles for article (PubMed ID: 12861105)
1. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.
Ponce IM; Caballero T; Reche M; Piteiro AB; López-Serrano MC; Fontán G; López-Trascasa M
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):632-7. PubMed ID: 12086372
[TBL] [Abstract][Full Text] [Related]
3. Clinical problems in the C1-inhibitor deficient patient.
Agostoni A; Cicardi M; Cugno M; Storti E
Behring Inst Mitt; 1993 Dec; (93):306-12. PubMed ID: 8172581
[TBL] [Abstract][Full Text] [Related]
4. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Cugno M; Castelli R; Cicardi M
Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
[TBL] [Abstract][Full Text] [Related]
5. Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor.
Kleiner GI; Giclas P; Stadtmauer G; Cunningham-Rundles C
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):461-4. PubMed ID: 11345293
[TBL] [Abstract][Full Text] [Related]
6. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
Alsenz J; Loos M
Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
[TBL] [Abstract][Full Text] [Related]
7. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: does danazol work?
Gaur S; Cooley J; Aish L; Weinstein R
Am J Hematol; 2004 Nov; 77(3):296-8. PubMed ID: 15495244
[TBL] [Abstract][Full Text] [Related]
9. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune C1 inhibitor deficiency: report of eight patients.
Cicardi M; Bisiani G; Cugno M; Späth P; Agostoni A
Am J Med; 1993 Aug; 95(2):169-75. PubMed ID: 8356982
[TBL] [Abstract][Full Text] [Related]
11. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
12. Urticaria, angioedema, and autoimmunity.
Zuraw BL
Clin Lab Med; 1997 Sep; 17(3):559-69. PubMed ID: 9316773
[TBL] [Abstract][Full Text] [Related]
13. Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins.
Geha RS; Quinti I; Austen KF; Cicardi M; Sheffer A; Rosen FS
N Engl J Med; 1985 Feb; 312(9):534-40. PubMed ID: 3918266
[TBL] [Abstract][Full Text] [Related]
14. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.
Alsenz J; Lambris JD; Bork K; Loos M
J Clin Invest; 1989 Jun; 83(6):1794-9. PubMed ID: 2723058
[TBL] [Abstract][Full Text] [Related]
15. Acquired C1-inhibitor deficiency.
Frank M
Behring Inst Mitt; 1989 Jul; (84):161-4. PubMed ID: 2679531
[No Abstract] [Full Text] [Related]
16. [Angioedema caused by splenectomy with malignant lymphoma followed by multiple myeloma 7 years later].
Shahar A; Sharon R; Lorber M; Pollack S
Harefuah; 1997 May; 132(9):624-6, 679. PubMed ID: 9225574
[TBL] [Abstract][Full Text] [Related]
17. [Angioedema due to acquired complement-C1-inhibitor deficiency in a female patient with non-Hodgkin lymphoma and autoimmune hemolytic anemia].
Beretta KR; Späth PJ; Pedrazzini A; Martinelli G; Cavalli F
Schweiz Med Wochenschr; 1991 Jun; 121(25):943-7. PubMed ID: 1862309
[TBL] [Abstract][Full Text] [Related]
18. [C1 inhibitor deficiency. Heredity and acquired forms. Symptoms, diagnostic and therapeutic problems].
Obtułowicz K; Kapusta M; Obtułowicz A; Mazurkiewicz A
Przegl Lek; 2002; 59(6):438-41. PubMed ID: 12418282
[TBL] [Abstract][Full Text] [Related]
19. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.
Wagenaar-Bos IG; Drouet C; Aygören-Pursun E; Bork K; Bucher C; Bygum A; Farkas H; Fust G; Gregorek H; Hack CE; Hickey A; Joller-Jemelka HI; Kapusta M; Kreuz W; Longhurst H; Lopez-Trascasa M; Madalinski K; Naskalski J; Nieuwenhuys E; Ponard D; Truedsson L; Varga L; Nielsen EW; Wagner E; Zingale L; Cicardi M; van Ham SM
J Immunol Methods; 2008 Sep; 338(1-2):14-20. PubMed ID: 18655790
[TBL] [Abstract][Full Text] [Related]
20. [Profhylaxis and treatment of hereditary and acquired angioedema at HUB; use of the C1-esterase inhibitor].
Pastó Cardona L; Bordas Orpinell J; Mercadal Orfila G; Pérez de la Vara A; Jódar Massanés R
Farm Hosp; 2003; 27(6):346-52. PubMed ID: 14974880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
